We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Chronic Exposure to Bacterial Superantigens Induces Diabetes-Like Symptoms in Rabbit Model

By LabMedica International staff writers
Posted on 14 Jun 2015
Print article
Image: Scanning electron micrograph (20,000x) of a strain of Staphylococcus aureus (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
Image: Scanning electron micrograph (20,000x) of a strain of Staphylococcus aureus (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
Researchers working with a rabbit model have shown that chronic exposure to the toxin produced by the bacterium Staphylococcus aureus can induce metabolic changes similar to those seen in type II diabetes.

In a recent study, investigators at the University of Iowa (Iowa City, USA) focused on the S. aureus superantigen toxic shock syndrome toxin-1 (TSST-1).

Superantigens (SAgs) are a class of antigens which cause nonspecific activation of T-cells resulting in polyclonal T-cell activation and massive cytokine release. SAgs can be produced by pathogenic microbes (including viruses, mycoplasma, and bacteria) as a defense mechanism against the immune system. Compared to a normal antigen-induced T-cell response where 0.01%–0.1% of the body’s T-cells are activated, these SAgs are capable of activating up to 25% of the body’s T-cells. The large number of activated T-cells generates a massive immune response which is not specific to any particular epitope on the SAg, thus undermining one of the fundamental strengths of the adaptive immune system, that is, its ability to target antigens with high specificity.

The investigators reported in the February 24, 2015, online edition of the journal mBio that rabbits experiencing chronic exposure to the S. aureus toxin developed impaired glucose tolerance, systemic inflammation, and elevated endotoxin levels in the bloodstream, all of which are common characteristics of type II diabetes. Additional experiments showed that cultures of fat cells (adipocytes) exposed to the toxin developed diabetes type II-like glucose intolerance.

"We basically reproduced Type II diabetes in rabbits simply through chronic exposure to the staph superantigen," said senior author Dr. Patrick Schlievert, professor of microbiology at the University of Iowa. "What we are finding is that as people gain weight, they are increasingly likely to be colonized by staph bacteria—to have large numbers of these bacteria living on the surface of their skin. People who are colonized by staph bacteria are being chronically exposed to the superantigens the bacteria are producing."

"I think we have a way to intercede here and alter the course of diabetes," said Dr. Schlievert. "We are working on a vaccine against the superantigens and we believe that this type of vaccine could prevent the development of type II diabetes."

Related Links:

University of Iowa


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.